z-logo
open-access-imgOpen Access
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
Author(s) -
B. Joseph Elmunzer,
James M. Scheiman,
Glen A. Lehman,
Amitabh Chak,
Patrick Mosler,
Peter Higgins,
Rodney A. Hayward,
Joseph Romagnuolo,
Grace H. Elta,
Stuart Sherman,
Akbar K. Waljee,
Aparna Repaka,
Matthew R. Atkinson,
Gregory A. Coté,
Richard S. Kwon,
Lee McHenry,
Cyrus Piraka,
Erik Wamsteker,
James L. Watkins,
Sheryl Korsnes,
Suzette E. Schmidt,
Sarah M. Turner,
Sylvia Nicholson,
Evan L. Fogel
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1111103
Subject(s) - medicine , randomized controlled trial , pancreatitis , surgery
Preliminary research suggests that rectally administered nonsteroidal antiinflammatory drugs may reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom